查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612566

生物樣本處理市場：按類型、產品類型、最終用途、應用分類 - 2025-2030 年全球預測

Biological Sample Handling Market by Type (Cellular & Genetic Material, Saliva Samples, Stool Samples), Product (Blood Collection Kits, Swabs, Viral Transport Media), End-Use, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生物樣本處理市場價值為186.2億美元，預計到2024年將達到198.5億美元，複合年成長率為6.47%，到2030年將達到288.8億美元。

生物樣本處理市場包括有效管理、處理和保存生物樣本所需的廣泛活動。這個過程對於保持診斷測試、藥物發現和生物樣本庫中使用的樣本的完整性和活力至關重要。臨床試驗、流行病學研究和個人化醫療對準確可靠結果的需求不斷成長，因此需要強大的樣本處理實踐。樣本處理應用範圍廣泛，包括臨床實驗室、醫院、研究機構和製藥公司。影響成長的關鍵因素包括慢性病的增加、生物技術的進步以及需要高品質樣本管理的基因組研究的擴展。此外，精準醫療和個人化醫療日益受到關注，需要加強處理程序。自動化和創新技術有新的機遇，例如冷凍保存和自動儲存系統，可顯著提高樣品管理的效率。公司可以透過利用區塊鏈實現資料和利用人工智慧進行預測樣本分析等領域來獲得競爭優勢。然而，市場開拓的挑戰包括嚴格的監管要求、與先進處理技術相關的高成本以及新興地區的意識有限。品管問題也對市場開拓構成重大風險。最佳創新領域包括改進永續性實踐、整合物聯網進行即時監控以及增強生物資訊學以實現更好的資料管理。研究新的保存方法以及開發環保且具成本效益的保存解決方案也可以推動成長。該市場本質上是高度動態的，重點關注技術進步和主要企業之間的夥伴關係，以簡化業務並擴大其影響範圍。為了緩解挑戰並有效抓住新機遇，企業應優先考慮持續創新和策略聯盟。

主要市場統計
基準年[2023] 186.2億美元
預計年份 [2024] 198.5億美元
預測年份 [2030] 288.8億美元
複合年成長率（%） 6.47%

市場動態：揭示快速發展的生物樣本處理市場的關鍵市場洞察

供需的動態交互作用正在改變生物樣本處理市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 個人化醫療保健中對液體樣本管理和處理的需求不斷增加
    • 基因組學和蛋白​​質組學的需求不斷成長以及生物銀行的增加
    • 生物標記分析的快速成長和對先進樣品處理的需求
  • 市場限制因素
    • 與生物樣品處理相關的嚴格規定
  • 市場機會
    • 增加對生命科學研發活動的投資
    • 樣品處理的技術進步與創新
  • 市場挑戰
    • 操作複雜性和對特定處理通訊協定的需求

波特五力：駕馭生物樣本處理市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解生物樣本處理市場的外部影響

外部宏觀環境因素在塑造生物樣本處理市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解生物樣本處理市場的競爭格局

對生物樣本處理市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣生物樣本處理市場供應商的績效評估

FPNV 定位矩陣是評估生物樣本處理市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製生物樣本處理市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對生物樣本處理市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 個人化醫療保健中對體液樣本管理和處理的需求不斷增加
      • 基因組學和蛋白​​質組學的需求不斷成長以及生物銀行實踐的增加
      • 生物標記分析快速增加以及對先進樣品處理的需求
    • 抑制因素
      • 與生物樣品處理相關的嚴格規定
    • 機會
      • 增加對生命科學研發活動的投資
      • 樣品處理的技術進步與創新
    • 任務
      • 操作複雜性和對特定處理通訊協定的需求
  • 市場區隔分析
    • 產品：更多使用採血套件和拭子在運輸過程中保存病毒樣本
    • 最終用途：在醫院中更多地採用生物樣本處理解決方案，促進主動的健康管理
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章生物樣本處理市場：依類型

  • 細胞和遺傳物質
  • 唾液樣本
  • 糞便樣本
  • 尿液樣本

第7章生物樣本處理市場：依產品

  • 血液採集套件
  • 棉花棒
    • 鼻拭子
    • 鼻咽拭子
    • 口咽拭子
  • 病毒運輸媒介

第8章生物樣本處理市場：依最終用途

  • 診斷中心
  • 居家護理
  • 醫院/診所

第9章生物樣本處理市場：依應用分類

  • 診斷
  • 調查

第10章美洲生物樣本處理市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區生物樣本處理市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的生物樣本處理市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • MedLife 使用無人機運輸實驗室樣本
    • BioLizard 與 Parean Biotechnologies 宣布合作
    • MolGen 收購 Synchron Lab Automation
  • 戰略分析和建議

公司名單

  • Accelerated Laboratory Logistics
  • Alliance Pharma PLC
  • Azenta Life Sciences
  • BioDock Limited
  • BioLife Solutions Inc.
  • Clinigen Group
  • Cryoniss
  • Cryoport Systems, LLC
  • Discovery Life Sciences
  • Eppendorf SE
  • Hamilton Company
  • Infiuss Health
  • Labtoo
  • Marken by United Parcel Service, Inc.
  • Mercury Business Services
  • MLM Medical Labs
  • Oximio
  • PrecisionMed, LLC
  • ReproCELL Inc.
  • SAROUTE Co., Ltd.
  • SPT Labtech Ltd.
  • Thermo Fisher Scientific Inc.
  • Ziath Ltd.
Product Code: MRR-757B1C9CB0B6

The Biological Sample Handling Market was valued at USD 18.62 billion in 2023, expected to reach USD 19.85 billion in 2024, and is projected to grow at a CAGR of 6.47%, to USD 28.88 billion by 2030.

The biological sample handling market encompasses a wide range of activities necessary for the effective management, processing, and preservation of biological samples. This process is vital for maintaining the integrity and viability of samples used in diagnostic testing, drug discovery, and biobanking. The necessity of robust sample handling practices arises from the increased demand for precise and reliable results in clinical trials, epidemiological studies, and personalized medicine. Applications of sample handling are broad, spanning clinical laboratories, hospitals, research institutions, and pharmaceutical companies. Key influencing growth factors include the rise in chronic diseases, advancements in biotechnologies, and the expansion of genomic research requiring high-quality sample management. Also noteworthy is the burgeoning interest in precision medicine and personalized healthcare, necessitating enhanced handling procedures. Emerging opportunities exist in automation and innovative technologies like cryopreservation and automated storage systems, which can greatly enhance sample management efficiency. Companies can capitalize on areas such as blockchain for data integrity and AI for predictive sample analytics to gain a competitive edge. However, challenges to market growth include stringent regulatory requirements, high costs associated with advanced handling technologies, and limited awareness in developing regions. Quality control issues also pose a substantial risk to market development. The best areas for innovation involve improving sustainability practices, integrating IoT for real-time monitoring, and enhancing bioinformatics for better data management. Research into novel preservation methods and the development of eco-friendly, cost-effective storage solutions can also foster growth. The market is highly dynamic in nature, with a focus on technological advancements and partnerships among key players to streamline operations and expand reach. Businesses should prioritize continuous innovation and strategic collaborations to mitigate challenges and leverage emerging opportunities effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 18.62 billion
Estimated Year [2024] USD 19.85 billion
Forecast Year [2030] USD 28.88 billion
CAGR (%) 6.47%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biological Sample Handling Market

The Biological Sample Handling Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing need for fluid sample management and handling in personalized healthcare
    • Growing demand from genomics and proteomics and the rise in biobanking practices
    • Exponential growth of biomarker analysis and the need for sophisticated sample handling
  • Market Restraints
    • Strict regulations associated with biological sample handling
  • Market Opportunities
    • Increasing investment in life sciences R&D activities
    • Technological advancements and innovations in sample handling
  • Market Challenges
    • Complexity associated with operations and need for specific handling protocols

Porter's Five Forces: A Strategic Tool for Navigating the Biological Sample Handling Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biological Sample Handling Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biological Sample Handling Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biological Sample Handling Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biological Sample Handling Market

A detailed market share analysis in the Biological Sample Handling Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biological Sample Handling Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biological Sample Handling Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biological Sample Handling Market

A strategic analysis of the Biological Sample Handling Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biological Sample Handling Market, highlighting leading vendors and their innovative profiles. These include Accelerated Laboratory Logistics, Alliance Pharma PLC, Azenta Life Sciences, BioDock Limited, BioLife Solutions Inc., Clinigen Group, Cryoniss, Cryoport Systems, LLC, Discovery Life Sciences, Eppendorf SE, Hamilton Company, Infiuss Health, Labtoo, Marken by United Parcel Service, Inc., Mercury Business Services, MLM Medical Labs, Oximio, PrecisionMed, LLC, ReproCELL Inc., SAROUTE Co., Ltd., SPT Labtech Ltd., Thermo Fisher Scientific Inc., and Ziath Ltd..

Market Segmentation & Coverage

This research report categorizes the Biological Sample Handling Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Cellular & Genetic Material, Saliva Samples, Stool Samples, and Urine Samples.
  • Based on Product, market is studied across Blood Collection Kits, Swabs, and Viral Transport Media. The Swabs is further studied across Nasal Swabs, Nasopharyngeal Swabs, and Oropharyngeal Swabs.
  • Based on End-Use, market is studied across Diagnostic Centers, Homecare, and Hospitals & Clinics.
  • Based on Application, market is studied across Diagnostics and Research.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need for fluid sample management and handling in personalized healthcare
      • 5.1.1.2. Growing demand from genomics and proteomics and the rise in biobanking practices
      • 5.1.1.3. Exponential growth of biomarker analysis and the need for sophisticated sample handling
    • 5.1.2. Restraints
      • 5.1.2.1. Strict regulations associated with biological sample handling
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment in life sciences R&D activities
      • 5.1.3.2. Technological advancements and innovations in sample handling
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity associated with operations and need for specific handling protocols
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing usage of blood collection kits and swabs for preserving viral samples during transportation
    • 5.2.2. End-Use: Increasing adoption of biological sample handling solutions in hospitals promoting proactive health management
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biological Sample Handling Market, by Type

  • 6.1. Introduction
  • 6.2. Cellular & Genetic Material
  • 6.3. Saliva Samples
  • 6.4. Stool Samples
  • 6.5. Urine Samples

7. Biological Sample Handling Market, by Product

  • 7.1. Introduction
  • 7.2. Blood Collection Kits
  • 7.3. Swabs
    • 7.3.1. Nasal Swabs
    • 7.3.2. Nasopharyngeal Swabs
    • 7.3.3. Oropharyngeal Swabs
  • 7.4. Viral Transport Media

8. Biological Sample Handling Market, by End-Use

  • 8.1. Introduction
  • 8.2. Diagnostic Centers
  • 8.3. Homecare
  • 8.4. Hospitals & Clinics

9. Biological Sample Handling Market, by Application

  • 9.1. Introduction
  • 9.2. Diagnostics
  • 9.3. Research

10. Americas Biological Sample Handling Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biological Sample Handling Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biological Sample Handling Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. MedLife to Transport Lab Samples with Drones
    • 13.3.2. BioLizard and Parean Biotechnologies Announce Partnership
    • 13.3.3. MolGen Acquires Synchron Lab Automation
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accelerated Laboratory Logistics
  • 2. Alliance Pharma PLC
  • 3. Azenta Life Sciences
  • 4. BioDock Limited
  • 5. BioLife Solutions Inc.
  • 6. Clinigen Group
  • 7. Cryoniss
  • 8. Cryoport Systems, LLC
  • 9. Discovery Life Sciences
  • 10. Eppendorf SE
  • 11. Hamilton Company
  • 12. Infiuss Health
  • 13. Labtoo
  • 14. Marken by United Parcel Service, Inc.
  • 15. Mercury Business Services
  • 16. MLM Medical Labs
  • 17. Oximio
  • 18. PrecisionMed, LLC
  • 19. ReproCELL Inc.
  • 20. SAROUTE Co., Ltd.
  • 21. SPT Labtech Ltd.
  • 22. Thermo Fisher Scientific Inc.
  • 23. Ziath Ltd.

LIST OF FIGURES

  • FIGURE 1. BIOLOGICAL SAMPLE HANDLING MARKET RESEARCH PROCESS
  • FIGURE 2. BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BIOLOGICAL SAMPLE HANDLING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BIOLOGICAL SAMPLE HANDLING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOLOGICAL SAMPLE HANDLING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOLOGICAL SAMPLE HANDLING MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLULAR & GENETIC MATERIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SALIVA SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STOOL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD COLLECTION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY NASAL SWABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY NASOPHARYNGEAL SWABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY OROPHARYNGEAL SWABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VIRAL TRANSPORT MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. BIOLOGICAL SAMPLE HANDLING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 237. BIOLOGICAL SAMPLE HANDLING MARKET, FPNV POSITIONING MATRIX, 2023